These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22687734)

  • 1. [Medical economics research on awareness of community pharmacists about raising pharmaceutical questions regarding prescriptions issued by physicians].
    Shikamura Y; Oyama A; Takahashi J; Akagi Y; Negishi K; Ijyuin K; Kamimura N; Aoyama T
    Yakugaku Zasshi; 2012; 132(6):753-61. PubMed ID: 22687734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reduction of Medical Cost through Pharmaceutical Inquiries by Community Pharmacists and Relation with Iyaku Bungyo Rates: A Nationwide Survey on Prescription Inquiries].
    Shikamura Y; Mano Y; Komoda M; Negishi K; Sato T; Miyazaki S
    Yakugaku Zasshi; 2016; 136(9):1263-73. PubMed ID: 27592829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survey on the awareness of community pharmacists about raising pharmaceutical questions regarding prescriptions issued by physicians].
    Shikamura Y; Takahashi J; Oyama A; Negishi K; Ijyuin K; Kamimura N; Aoyama T
    Yakugaku Zasshi; 2011; 131(10):1509-18. PubMed ID: 21963979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy performance while providing continuous medication monitoring.
    Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
    J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a professional allowance.
    Benrimoj SI; Langford JH; Berry G; Collins D; Lauchlan R; Stewart K; Aristides M; Dobson M
    Pharmacoeconomics; 2000 Nov; 18(5):459-68. PubMed ID: 11151399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SETSUYAKU-BAG Campaign--investigation of outpatient's leftover drugs and promotion of proper reuse of leftover drugs to reduce medical expenses].
    Koyanagi K; Kubota T; Kobayashi D; Kihara T; Yoshida T; Miisho T; Saito Y; Uchigoshi H; Takaki J; Seo T; Shimazoe T
    Yakugaku Zasshi; 2013; 133(11):1215-21. PubMed ID: 23978848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug related problems in Belgian community pharmacies].
    Huysmans K; De Wulf I; Foulon V; De Loof H; Steurbaut S; Boussery K; De Vriese C; Lacour V; Van Hees T; De Meyer GR
    J Pharm Belg; 2014 Mar; (1):4-15. PubMed ID: 24804389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-guided academic detailing as part of a drug benefit program.
    Keys PW; Goetz CM; Keys PA; Sterchele JA; Snedden TM; Livengood BH
    Am J Health Syst Pharm; 1995 Oct; 52(20):2199-203; discussion 22034. PubMed ID: 8564590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Avoidance of Adverse Drug Reactions by Pharmacists (Through the PreAVOID Report)].
    Tanigawa K
    Rinsho Byori; 2016 Sep; 64(9):1082-1084. PubMed ID: 30609463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia.
    Ping CC; Bahari MB; Hassali MA
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):82-9. PubMed ID: 17879323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of inquiries about prescriptions at the pharmacy of Gifu Pharmaceutical University].
    Niwa K; Adachi T; Takahashi C; Nakamura M; Tagashira M; Kubota M; Hirano K
    Yakugaku Zasshi; 2001 Nov; 121(11):837-44. PubMed ID: 11725553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in Medical Safety Interventions Conducted by Ward-based Pharmacists since the Introduction of Their Services in Complex Medical Ward].
    Senaha H; Myotoku M; Tomida Y; Murayama Y; Nakanishi A; Iwamoto C; Tagawa M; Hata A; Kokado M; Obata A; Kawaguchi S
    Yakugaku Zasshi; 2015; 135(9):1069-76. PubMed ID: 26329553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
    J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nine-year sustained cost-containment impact of swiss pilot physicians-pharmacists quality circles.
    Niquille A; Ruggli M; Buchmann M; Jordan D; Bugnon O
    Ann Pharmacother; 2010 Apr; 44(4):650-7. PubMed ID: 20215496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Effect of Pharmacist-led Psychiatric Pharmacotherapy Conferences on the Appropriate Use of Antipsychotics].
    Sano T; Inoue M; Takizawa M; Shimamori Y; Kurosawa N
    Yakugaku Zasshi; 2017; 137(5):603-610. PubMed ID: 28458292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of drug information provided by the pharmacists in the intensive care unit].
    Imaura M; Kohata Y; Kobayashi K; Takahashi H; Yokoyama H; Akase T; Yamada Y
    Yakugaku Zasshi; 2010 Oct; 130(10):1361-8. PubMed ID: 20930489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.